[Forschungsbericht] Der Markt für gutartige Prostata-Hyperplasie-Geräte wird voraussichtlich ab US-Dollar wachsen 2.078,78 Millionen US-Dollar im Jahr 2021 auf 3.467,31 Millionen US-Dollar im Jahr 2028; es wird geschätzt, dass es von 2022 bis 2028 mit einer CAGR von 7,6 % wachsen wird.
Benigne Prostatahyperplasie (BPH) ist eine Prostatavergrößerung, die durch übermäßiges Zellwachstum in der Prostata verursacht wird. BPH ist eine gutartige (nicht krebsartige) Prostataerkrankung. Nicht krebsartige Zustände sind normalerweise nicht tödlich und breiten sich nicht auf andere Körperteile aus (metastasieren). BPH erhöht das Prostatakrebsrisiko nicht; Solange es keine Symptome zeigt, wird BPH nicht als Gesundheitsproblem betrachtet. Fast alle Männer haben im Alter von 70 Jahren ein gewisses Prostatawachstum. Älter werden, mehr Bauchfett haben (auch bekannt als abdominale Fettleibigkeit) und sich nicht genug bewegen, um das Risiko der Entwicklung von BPH zu erhöhen.
Der Markt für gutartige Prostatahyperplasie-Geräte ist in Produkt, Verfahrenstyp, Endverbraucher und Region unterteilt. Geografisch ist der Markt grob in Nordamerika, Europa, den asiatisch-pazifischen Raum, den Nahen Osten & Afrika und Süd- & Zentralamerika. Dieser Bericht bietet Einblicke und eingehende Analysen des Marktes, wobei Parameter wie Markttrends, Marktdynamik und die Wettbewerbsanalyse der weltweit führenden Marktteilnehmer hervorgehoben werden. < /p>
Strategische Einblicke
Lukrative Regionen für den Markt für gutartige prostatische hyperplastische Geräte
Markteinblicke
Zunahme der Prävalenz der benignen Prostatahyperplasie zusammen mit wachsenden Risikofaktoren und ein Anstieg der Investitionen, Mittel und Zuschüsse für die Forschung in der BPH-Behandlung, um den Markt für benigne Prostatahyperplasie voranzutreiben.
Laut dem National Center for Biotechnology Information (NCBI) gehört BPH zu den häufigsten Erkrankungen bei älteren Männern und die Hauptursache für untere Symptome der Harnwege (LUTS). Nach dem 40. Lebensjahr steigt die BPH-Prävalenz an und erreicht mit 90 Jahren einen Höchststand von 60 %. Die histologische Prävalenz der BPH liegt laut Autopsiestudien bei 8 %, 50 % und 80 % im vierten, sechsten, bzw. neunten Lebensjahrzehnt eines Mannes. Das Alter hat sich in Beobachtungsstudien, die in Europa, den USA und Asien durchgeführt wurden, auch als Risikofaktor für das Auftreten und Fortschreiten der klinischen BPH erwiesen. Laut Statistiken der Krimpen and Baltimore Longitudinal Study of Aging wächst die Prostata bei älteren Männern mit einer Rate von 2,0 % bis 2,5 % pro Jahr. Eine anhaltende Prostatavergrößerung ist ein Risikofaktor für die Entwicklung von LUTS, und größere Prostata sind mit einer gutartigen Prostatavergrößerung (BPE) verbunden, die das Risiko der Entwicklung einer klinischen BPH und Harninkontinenz auslöst.
Laut NCBI-Daten korreliert eine erhöhte Adipositas positiv mit dem Prostatavolumen. In zahlreichen Studiengruppen wurde festgestellt, dass das Körpergewicht, der Body-Mass-Index (BMI) und der Taillenumfang positiv mit dem Prostatavolumen korrelieren. Darüber hinaus zeigen epidemiologische Daten, dass Fettleibigkeit die Notwendigkeit einer BPH-Operation und der Einleitung einer BPH-Behandlung erhöhen kann.
Laut dem American Journal of Men's Health (AJMH) gab es im Jahr 2019 weltweit 11,26 Millionen neue Fälle und 1,86 Millionen Jahre mit Behinderung (YLD) aufgrund von BPH. Die Inzidenz von BPH stieg um 105,7 %, und YLD stieg zwischen 1990 und 2019 weltweit um 110,6 %. Die absoluten Inzidenz- und YLD-Zahlen stiegen in diesem Zeitraum weltweit erheblich an, hauptsächlich aufgrund des Bevölkerungswachstums und der Alterung. Nach Schätzungen der UROLOGY FOUNDATION steigt die Prävalenz von BPH im Vereinigten Königreich von 50 % bei Männern im Alter von 50 bis 60 Jahren auf 90 % bei Männern im Alter von 80 Jahren und darüber. Einige Männer entwickeln eine plötzliche akute Retention, dh die Unfähigkeit, Wasser zu lassen. Die Behandlungsoption für BPH umfasst Operationen wie die transurethrale Resektion der Prostata (TURP), die offene Prostatektomie und minimalinvasive Behandlungen wie die transurethrale Nadelablation (TUNA). Bei minimal invasiven Behandlungen wie Radiofrequenzablation, Lasertherapie und Implantate werden gutartige Prostata-Hyperplasie-Vorrichtungen verwendet. Die Zunahme der Prävalenz der benignen Prostatahyperplasie und zunehmende Risikofaktoren verstärken daher die Nachfrage nach gutartigen Prostatahyperplasie-Geräten.
Produktinfos
Basierend auf dem Produkt wird der Markt für gutartige Prostatahyperplasiegeräte in Resektoskope,
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
The global benign prostatic hyperplasic devices market based on product is resectoscopes, radiofrequency ablation devices, urology laser, prostatic stents, and implants. The resectoscopes segment is likely to hold the largest share of the market in 2022. However, the urology lasers segment is anticipated to register the highest CAGR of 8.4% in the market during the forecast period.
The benign prostatic hyperplasic devices market majorly consists of the players such as KARL STORZ SE & Co. KG; Richard Wolf GmbH; Olympus Corporation; Urologix, LLC.; Boston Scientific Corporation; Butterfly; TELEFLEX Incorporated; OmniGuide Holdings, Inc.; Convergent Laser Technologies; ProArc; and Olympus Corporation.
The factors that are driving and restraining factors that will affect the benign prostatic hyperplasic devices market in the coming years. Factors such as the rise in the prevalence of benign prostatic hyperplasia amongst men, along with increasing risk factors and rise in investments, funds, and grants for research in BPH treatment. However, less awareness about prostate health among men will hamper the market growth.
Benign prostatic hyperplasia (BPH) is a prostate enlargement caused by excessive cell growth in the prostate. BPH is a benign (non-cancerous) prostate condition. Non-cancerous conditions are not usually fatal and do not spread (metastasize) to other body parts. BPH doesn't raise the risk of prostate cancer; unless it manifests symptoms, BPH isn't considered a health issue. Almost all men will have some prostate growth by the age of 70. Getting older, having more belly fat (also known as abdominal obesity), and not getting enough exercise to raise the risk of developing BPH.
The List of Companies - Benign Prostatic Hyperplasic Devices Market
- KARL STORZ SE & Co. KG
- Richard Wolf GmbH
- Olympus Corporation
- Urologix, LLC.
- Boston Scientific Corporation
- Butterfly
- TELEFLEX Incorporated
- OmniGuide Holdings, Inc.
- Convergent Laser Technologies
- ProArc
- Olympus Corporation
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Related Reports
Jul 2022
Colonoscopes Market
Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Fiber Optic Colonoscopy Devices, Video Colonoscopy Devices); Application (Colorectal Cancer, Lynch Syndrome, Ulcerative Colitis, Crohn's Disease, Polyp); End User (Hospitals, Ambulatory Surgery Center, Others), and Geography
Jul 2022
Noninvasive Fat Reduction Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Technology (Cryolipolysis, Laser Lipolysis, Ultrasound, and Others), End User (Hospitals, Dermatology Clinics & Cosmetic Clinics, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Jul 2022
Medical Ultrasound Flow Meter Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Implementation Type (Clamp-On, Inline, and Others), Technology (Doppler, Transit Time, and Hybrid), Application (Heart and Lung Machines, Extracorporeal Membrane Oxygenation, Perfusion, Organ Transportation Systems, and Others), End User (Hospitals and Clinics, Ambulatory Surgical Centers, Research Laboratories, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Jul 2022
Rapid Test Kits Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Rapid Antigen Testing, Rapid Antibody Testing, and Others), Product (Over-the-Counter Rapid Testing Kit and Professional Rapid Testing Kit), Technology (Lateral Flow Assay, Solid Phase, Agglutination, Immunospot Assay, and Cellular Component-Based), Application (Blood Glucose Testing, Infectious Disease Testing, Pregnancy and Fertility, Cardiometabolic Testing, and Others), End User (Hospital and Clinics, Home Care, Diagnostics Centers, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Jul 2022
Osteoarthritis Therapy Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Therapy Type [Transcutaneous Electrical Nerve Stimulation (TENS), Occupational Therapy, Physical Therapy, Platelet-Rich Plasma Therapy and Stromal Vascular Fraction, Prolotherapy, and Others], Disease Indication (Knee Osteoarthritis, Spine Osteoarthritis, Foot and Ankle Osteoarthritis, Shoulder Osteoarthritis, Hand Osteoarthritis, and Others), End User (Hospitals & Clinics, Specialty Clinics, Ambulatory Surgical Centers, Homecare, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Jul 2022
Bariatric Surgeries Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Type [Adjustable Gastric Bands (AGB), Sleeve Gastrectomy, Gastric Bypass, Biliopancreatic Diversion with Duodenal Switch (BPD-DS), and Others], End User (Hospitals and Ambulatory Surgical Centers), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Jul 2022
Post-Acute Care Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Service Type (Skilled Nursing Facilities, Inpatient Rehabilitation Facilities, Long-Term Care Hospitals, Home Health Agency, and Others), Age (Elderly, Adult, and Others), Disease Conditions (Amputations, Wound Management, Brain Injury and Spinal Cord Injury, Neurological Disorders, and Others), and Geography
Jul 2022
Lung Cancer Therapy Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Therapy Type (Noninvasive and Minimally Invasive), Indication (Non-Small Cell Lung Cancer and Small Cell Lung Cancer), End User (Hospitals, Oncology Clinics, Research Centers, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)